Zomedica Corp. (ZOMDF)
0.084
+0.01
(+6.50%)
USD |
OTCM |
Oct 05, 16:00
Zomedica Free Cash Flow : -14.80M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.80M |
| March 31, 2026 | -17.36M |
| December 31, 2025 | -18.63M |
| September 30, 2025 | -23.82M |
| June 30, 2025 | -24.89M |
| March 31, 2025 | -26.87M |
| December 31, 2024 | -29.77M |
| September 30, 2024 | -19.68M |
| June 30, 2024 | -23.36M |
| March 31, 2024 | -21.16M |
| December 31, 2023 | -20.43M |
| September 30, 2023 | -2.950M |
| June 30, 2023 | -20.42M |
| March 31, 2023 | -18.72M |
| December 31, 2022 | -12.17M |
| September 30, 2022 | -38.76M |
| June 30, 2022 | -16.77M |
| March 31, 2022 | -14.74M |
| December 31, 2021 | -14.72M |
| September 30, 2021 | -12.67M |
| June 30, 2021 | -13.54M |
| March 31, 2021 | -17.22M |
| December 31, 2020 | -16.73M |
| September 30, 2020 | -15.61M |
| June 30, 2020 | -13.13M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.93M |
| December 31, 2019 | -16.41M |
| September 30, 2019 | -17.80M |
| June 30, 2019 | -18.07M |
| March 31, 2019 | -12.49M |
| December 31, 2018 | -11.56M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -6.916M |
| June 30, 2017 | -6.978M |
| March 31, 2017 | -5.784M |
| December 31, 2016 | -4.769M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| February 29, 2016 | |
| November 30, 2015 | |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | -0.0431M |
| November 30, 2014 | -0.0145M |
| August 31, 2014 | -0.0621M |
| May 31, 2014 | -0.0595M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biomerica, Inc. | -3.422M |
| Univec, Inc. | -15.55M |
| Lantheus Holdings, Inc. | 382.42M |
| IDEXX Laboratories, Inc. | 1.233B |
| Neogen Corp. | 31.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.515M |
| Cash from Investing (Quarterly) | 0.3581M |
| Free Cash Flow Per Share (Quarterly) | -0.0034 |
| Free Cash Flow to Equity (Quarterly) | -3.144M |
| Free Cash Flow to Firm (Quarterly) | -3.324M |
| Free Cash Flow Yield | -17.98% |